Lonza in Belgium
E-mail: -
Web: https://pharma.lonza.com/
Addresses:
-
Office 2 Lonza in Belgium
Avenue des Biolleux, 14, Parc Industriel de Petit-Rechain, Verviers 4800
Phone: +32 8732 1611
Fax: +32 8735 1967
-
Office 1 Lonza in Belgium
Rijksweg 11, Bornem
Phone: +32 (0) 3890 0511
Fax: -
Other Lonza's locations around the world
Clinical Trials sponsored by Lonza
-
Lonza Ltd.FullførtFriske Frivillige | Gjenoppretting | EndotelfunksjonTyskland
-
Biofortis, Merieux NutriSciencesLonza Inc.FullførtTarmmikrobiotaForente stater
-
KGK Science Inc.Lonza Inc.Fullført
-
Biofortis, Merieux NutriSciencesLonza Inc.Fullført
-
Applied Science & Performance InstituteLonza Ltd.FullførtOksidativt stress | Muskel sårhet | Muskelstyrke | Muskelskade | MotstandstreningForente stater
-
Applied Science & Performance InstituteLonza Ltd.FullførtKroppssammensetning | Oksidativt stress | Muskelstyrke | Muskelskade | MotstandstreningForente stater
-
Applied Science & Performance InstituteLonza Ltd.FullførtOksidativt stress | Muskelstyrke | Muskelskade | Motstandstrening | ImmunsuppresjonForente stater
-
Applied Science & Performance InstituteLonza Ltd.FullførtKroppssammensetning | Oksidativt stress | Muskelstyrke | Muskelskade | MotstandstreningForente stater
-
Fred Hutchinson Cancer CenterLonza Walkersville, Inc.RekrutteringStage IV Bukspyttkjertelkreft AJCC v8 | Metastatisk bukspyttkjertelduktalt adenokarsinomForente stater
About Lonza
Innovation lies at the heart of our mission to enable our customers to meet challenging deadlines and address their patients’ needs. Research & Development (R&D) plays a central role in how we approach innovation. It provides us with a long-term vision and ensures we make appropriate investments into extending our technology and capabilities to develop the tools we need for our future success.
Our scientific mindset, 360º view of industry trends and experience in transforming discovery into manufacturing applications, have been applied on multiple fronts throughout 2020. Our 14 R&D sites worldwide are an integral part of our global network and support innovation across the business.
Innovation does not happen in isolation. It is underpinned by strong synergies across all our R&D focus areas. Our R&D group is active in viral vectors, cell line construction, cell culture media, cell and gene therapies, capsule design and manufacturing, other oral dosage forms, chemical active pharmaceutical ingredients (APIs) and parenteral formulation and delivery. It is also involved in bio manufacturing and digital technology. Our key areas of interest are summarized here.